Focus: Sirius Medical develops surgical navigation software for precise tumor localization in oncology, focusing on intraoperative guidance during breast and other surgical procedures. The company is a specialized medical device/software biotech founded in 2017 and based in Eindhoven, Netherlands.
Profile data last refreshed 1h ago · AI intelligence enriched 1w ago
Cooling — net -7 jobs in 30d
6 added, 13 removed. Slower than typical.
Sirius Medical is a pre-revenue surgical oncology device play with early commercialization signals; best suited for commercial, supply chain, or business development professionals willing to accept clinical and market risk in exchange for equity upside and ground-floor opportunity.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Sirius Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sirius Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub